vs

Side-by-side financial comparison of Immunovant, Inc. (IMVT) and High Roller Technologies, Inc. (ROLR). Click either name above to swap in a different company.

Immunovant, Inc. is the larger business by last-quarter revenue ($8.4M vs $6.3M, roughly 1.3× High Roller Technologies, Inc.). High Roller Technologies, Inc. runs the higher net margin — 58.4% vs -899.0%, a 957.4% gap on every dollar of revenue. On growth, Immunovant, Inc. posted the faster year-over-year revenue change (140.7% vs -16.4%). High Roller Technologies, Inc. produced more free cash flow last quarter ($-90.0K vs $-59.8M).

Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative monoclonal antibody therapies for patients with serious, rare autoimmune and inflammatory diseases. Its lead product candidate covers multiple autoimmune indications, with core U.S. operations and a global market expansion strategy.

S&S – Sansei Technologies is an American company known for its pneumatically powered amusement rides and roller coaster designing.

IMVT vs ROLR — Head-to-Head

Bigger by revenue
IMVT
IMVT
1.3× larger
IMVT
$8.4M
$6.3M
ROLR
Growing faster (revenue YoY)
IMVT
IMVT
+157.2% gap
IMVT
140.7%
-16.4%
ROLR
Higher net margin
ROLR
ROLR
957.4% more per $
ROLR
58.4%
-899.0%
IMVT
More free cash flow
ROLR
ROLR
$59.8M more FCF
ROLR
$-90.0K
$-59.8M
IMVT

Income Statement — Q4 FY2024 vs Q3 FY2025

Metric
IMVT
IMVT
ROLR
ROLR
Revenue
$8.4M
$6.3M
Net Profit
$-75.3M
$3.7M
Gross Margin
Operating Margin
-896.2%
1.3%
Net Margin
-899.0%
58.4%
Revenue YoY
140.7%
-16.4%
Net Profit YoY
-26.7%
831.9%
EPS (diluted)
$-0.50
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMVT
IMVT
ROLR
ROLR
Q3 25
$6.3M
Q2 25
$6.9M
Q1 25
$6.8M
Q3 24
$7.5M
Q1 24
$8.4M
Q4 23
$8.9M
Q3 23
$3.6M
Q2 23
$4.1M
Net Profit
IMVT
IMVT
ROLR
ROLR
Q3 25
$3.7M
Q2 25
$-592.0K
Q1 25
$-3.3M
Q3 24
$-501.0K
Q1 24
$-75.3M
Q4 23
$-51.4M
Q3 23
$-58.7M
Q2 23
$-73.9M
Operating Margin
IMVT
IMVT
ROLR
ROLR
Q3 25
1.3%
Q2 25
-7.2%
Q1 25
-47.4%
Q3 24
-6.3%
Q1 24
-896.2%
Q4 23
-576.8%
Q3 23
-1629.6%
Q2 23
-1819.1%
Net Margin
IMVT
IMVT
ROLR
ROLR
Q3 25
58.4%
Q2 25
-8.5%
Q1 25
-48.4%
Q3 24
-6.7%
Q1 24
-899.0%
Q4 23
-575.6%
Q3 23
-1642.3%
Q2 23
-1818.9%
EPS (diluted)
IMVT
IMVT
ROLR
ROLR
Q3 25
$0.39
Q2 25
$-0.07
Q1 25
$-0.39
Q3 24
$-0.07
Q1 24
$-0.50
Q4 23
$-0.36
Q3 23
$-0.45
Q2 23
$-0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMVT
IMVT
ROLR
ROLR
Cash + ST InvestmentsLiquidity on hand
$635.4M
$2.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$617.8M
$6.6M
Total Assets
$666.4M
$16.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMVT
IMVT
ROLR
ROLR
Q3 25
$2.7M
Q2 25
$2.7M
Q1 25
$3.5M
Q3 24
$1.3M
Q1 24
$635.4M
Q4 23
$690.9M
Q3 23
$269.9M
Q2 23
$330.0M
Stockholders' Equity
IMVT
IMVT
ROLR
ROLR
Q3 25
$6.6M
Q2 25
$2.6M
Q1 25
$2.8M
Q3 24
$-779.0K
Q1 24
$617.8M
Q4 23
$679.3M
Q3 23
$251.8M
Q2 23
$299.9M
Total Assets
IMVT
IMVT
ROLR
ROLR
Q3 25
$16.0M
Q2 25
$12.3M
Q1 25
$12.8M
Q3 24
$12.9M
Q1 24
$666.4M
Q4 23
$711.4M
Q3 23
$292.1M
Q2 23
$351.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMVT
IMVT
ROLR
ROLR
Operating Cash FlowLast quarter
$-59.7M
$-78.0K
Free Cash FlowOCF − Capex
$-59.8M
$-90.0K
FCF MarginFCF / Revenue
-714.4%
-1.4%
Capex IntensityCapex / Revenue
1.8%
0.2%
Cash ConversionOCF / Net Profit
-0.02×
TTM Free Cash FlowTrailing 4 quarters
$-214.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMVT
IMVT
ROLR
ROLR
Q3 25
$-78.0K
Q2 25
$-840.0K
Q1 25
$-3.6M
Q3 24
Q1 24
$-59.7M
Q4 23
$-47.1M
Q3 23
$-60.1M
Q2 23
$-47.4M
Free Cash Flow
IMVT
IMVT
ROLR
ROLR
Q3 25
$-90.0K
Q2 25
$-845.0K
Q1 25
$-3.6M
Q3 24
Q1 24
$-59.8M
Q4 23
$-47.2M
Q3 23
$-60.1M
Q2 23
$-47.4M
FCF Margin
IMVT
IMVT
ROLR
ROLR
Q3 25
-1.4%
Q2 25
-12.2%
Q1 25
-53.5%
Q3 24
Q1 24
-714.4%
Q4 23
-528.7%
Q3 23
-1682.4%
Q2 23
-1166.4%
Capex Intensity
IMVT
IMVT
ROLR
ROLR
Q3 25
0.2%
Q2 25
0.1%
Q1 25
0.2%
Q3 24
Q1 24
1.8%
Q4 23
1.5%
Q3 23
1.0%
Q2 23
1.1%
Cash Conversion
IMVT
IMVT
ROLR
ROLR
Q3 25
-0.02×
Q2 25
Q1 25
Q3 24
Q1 24
Q4 23
Q3 23
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMVT
IMVT

Segment breakdown not available.

ROLR
ROLR

Net Gaming Revenue$4.9M77%
Net Revenue Noncore Services$1.4M23%

Related Comparisons